FDA recall: Erectile dysfunction drug found in honey energy supplement
Briefly

FDA recall: Erectile dysfunction drug found in honey energy supplement
"The Food and Drug Administration issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found in the product, the agency said. "Akkarco LLC of Lorton, Virginia, is voluntarily recalling Ashfiat Alharamain Energy Support because the product contains undeclared Tadalafil, an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE5) inhibitors," the FDA said."
"Products that contain Tadalafil cannot be marketed as dietary supplements, the FDA said. Ashfiat Alharamain Energy Support is an "unapproved new drug for which safety and efficacy have not been established," they said. The product is sold nationwide on Amazon.com and other retail stores. Consumers are advised to consult a medical professional if they experiencing any adverse events or side effects related to the use of the product."
Akkarco LLC is voluntarily recalling Ashfiat Alharamain Energy Support after an undeclared tadalafil was found in the product. Tadalafil is an ingredient in FDA-approved treatments for male erectile dysfunction and belongs to the phosphodiesterase (PDE5) inhibitor class. Products that contain tadalafil cannot be marketed as dietary supplements. Ashfiat Alharamain Energy Support is considered an unapproved new drug for which safety and efficacy have not been established. The product is sold nationwide on Amazon.com and other retail stores. Consumers who experience adverse events or side effects after using the product are advised to consult a medical professional.
#fda-recall #tadalafil #dietary-supplements #product-safety
Read at ABC7 Los Angeles
Unable to calculate read time
[
|
]